12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Tuesday's intraday session, several health care stocks experienced significant movements. Akili, Cyclacel Pharmaceuticals, Eliem Therapeutics, GeneDx Hldgs, Dare Bioscience, and Lucid Diagnostics were among the gainers, with Akili leading at a 70.1% increase. On the downside, NRX Pharmaceuticals, Innovative Eyewear, Vaxxinity, Barinthus Biotherapeutics, Annovis Bio, and OpGen saw notable declines, with NRX Pharmaceuticals dropping by 23.9%.
April 30, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NRX Pharmaceuticals' shares fell by 23.9% to $2.7, with a market value of $28.3 million.
The decline in NRX Pharmaceuticals' stock price could be due to negative news or market reactions, impacting investor sentiment negatively.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Akili's stock surged by 70.1% to $0.4, with a market cap of $31.4 million.
The significant surge in Akili's stock price indicates strong investor confidence, potentially due to positive company developments or market conditions favoring health care stocks.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Cyclacel Pharmaceuticals' stock rose by 51.83% to $2.06, with a market cap of $2.7 million.
Cyclacel Pharmaceuticals' significant stock price increase may reflect investor optimism about the company's future prospects or reactions to recent positive news.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90